Autographa californica multiple nucleopolyhedrovirus (AcMNPV) ac92 is a core gene encoding a protein associated with occlusion derived virus (ODV), binds human P53 and also has flavin adenine dinucleotide linked sulfhydryl oxidase activity but its role in the virus life cycle is not known. To determine ac92 function a deletion virus (vAc 92KO ) was generated and transfected Sf9 cells revealed that vAc 92KO infection was restricted primarily to single cells and budded virus (BV) titer was reduced over 99.99%. However, viral DNA replication was unaffected and development of occlusion bodies in vAc 92KO -transfected cells evidenced progression to very late phases of viral infection. AC92 localized to both the cytoplasm and nucleus, and was also associated with BV as well as ODV. In BV AC92 was detected in BV envelope and nucleocapsid fractions. Finally it was shown that the ac92 homologue from the Group II alphabaculovirus Mamestra configurata NPV maco96 could only partially rescue vAc 92KO . Crown
Introduction
Baculoviridae comprises a large and diverse group of viruses which are pathogens of insects that are known to infect Lepidoptera, Hymenoptera and Diptera. During the typical biphasic infection cycle, two structurally and functionally distinct enveloped virion phenotypes are produced: occlusion derived virus (ODV) and budded virus (BV) (Miller, 1997; Rohrmann, 2008) . ODVs are occluded in the nucleus in a protein matrix that forms occlusion bodies which are required for interhost transmission of the virus. After release from occlusion bodies in the alkaline environment of the midgut lumen, ODVs initiate primary infection of host larvae. BVs are produced when nucleocapsids bud through the plasma membrane of the midgut epithelial cells or other tissues to initiate secondary infections within the infected animal.
Autographa californica multiple nucleopolyhedrovirus (AcMNPV), the archetype species of the alphabaculoviruses of the Baculoviridae, has a circular double-stranded DNA genome of approximately 134 kilobase pair (kbp) that contains 154 predicted open reading frames (ORFs) (Ayres et al., 1994) . One of the ORFs ac92 encodes a core gene conserved in all sequenced baculoviruses. It has been found that AC92 forms a complex with human tumor suppressor P53 and enhances P53-mediated apoptosis (Prikhod'ko et al., 1999) . AC92 and its homologues have been identified as structural components of ODV in multiple viruses by proteomic approaches (Braunagel et al., 2003; Deng et al., 2007; Perera et al., 2007) . Very recently, an in vitro study demonstrated that AC92 has a flavin adenine dinucleotide (FAD) linked sulfhydryl oxidase activity (Long et al., 2009) . It was suggested that the sulfhydryl oxidase may be required for regulating the redox state of replication factors or may be required for disulphide bonds in structural proteins. However, the role of AC92 in the AcMNPV infection cycle is not yet known. Previous attempts to inactivate ac92 by an insertion of lacZ were unsuccessful which suggests that ac92 is essential for the viral infection (Prikhod'ko et al., 1999) .
In this study, a knockout mutant was used to show that deletion of ac92 resulted in nearly complete loss of BV production. This indicates that ac92 is an essential gene and suggests that viral sulfhydryl oxidase is critical for AcMNPV replication. This study also determined AC92 localized to both the cytoplasm and nucleus as well as to BV and ODV during infection. Evolutionary conservation of function was investigated by repair of the ac92null virus with maco96, the ac92 homologue from Mamestra configurata NPV (MacoNPV).
Results

Construction of ac92null and repaired viruses
Using the AcMNPV bMON14272 bacmid, an ac92null bacmid was constructed based on homologous recombination in Escherichia coli ( Fig. 1) (Lin et al., 2001; Stewart et al., 2005) . To examine the effect of Virology 409 (2011) 38-45 ac92 deletion on virus infection and occlusion body morphogenesis, the polyhedrin and gfp genes were inserted into the polyhedrin locus of ac92null by transposition (vAc 92KO , Fig. 1 ). To confirm that any phenotype observed was due to the loss of ac92 a rescue virus (vAc 92KO-AC92HA ) was generated, in which ac92 driven by its predicted native late promoter with an HA epitope at the C-terminus was inserted into the polyhedrin locus of ac92null bacmid. A third virus was also generated to establish if the ac92 homologue from the group II alphabaculovirus MacoNPV maco96 can rescue the ac92 deletion. The maco96 driven by its predicted late promoter and tagged with HA epitope sequence at the 3' end of the ORF was inserted into the polyhedrin locus of ac92null to generate vAc 92KO-MACO96HA (Fig. 1) . The use of maco96 to provides the means to determine if the function of this core baculovirus protein was evolutionarily conserved. MACO96 has 50% identity to AC92 (Li et al., 2002) but retains the sulfhydryl oxidase domain identified by Long et al. (2009) . The wildtype construct, vAcBac, which serves as a positive control, was constructed by transposing polyhedrin and gfp gene into polyhedrin locus of AcMNPV bacmid bMON14272 ( Fig. 1 ).
Analysis of ac92 deletion and repair viruses in transfected Sf9 cells
To determine the effect of ac92 deletion on virus replication, bacmid DNAs of vAc 92KO , vAc 92KO-AC92HA , vAc 92KO-MACO96HA and vAcBac were transfected into Sf9 cells. In all the constructs the expression of gfp driven by the constitutive Orgyia pseudosugata MNPV ie1 promoter enables the monitoring of transfection by fluorescence microscopy ( Fig. 2A) . At 24 h post transfection (hpt), similar percentages of GFP positive cells were observed from all four viruses, indicating transfection efficiencies were comparable. As expected by 96 hpt the majority of Sf9 cells transfected with vAcBac showed infection as evidenced by the visual detection of GFP expression. In contrast, cells transfected with vAc 92KO showed only a very limited increase in the number of GFP expressing cells by 96 hpt compared to vAcBac. vAc 92KO-MACO96HA transfected cells showed a greater increase in the number of GFP-positive cells at 96 hpt compared to vAc 92KO , but was much lower compared to vAcBac. vAc 92KO-AC92HA showed a similar spread of infection to vAcBac which indicated that AC92HA which has the C-terminal HA epitope tag could rescue the ac92 deletion. These initial results therefore suggest that the deletion of ac92 reduces the production of infectious BV.
Light microscopy analysis showed that occlusion bodies (OBs) were produced by cells transfected with vAc 92KO , vAc 92KO-AC92HA , vAc 92KO-MACO96HA and vAcBac at 96 hpt. Significantly fewer cells with occlusion bodies were observed from cells transfected by vAc 92KO and vAc 92KO-MACO96HA which would be consistent with the reduced number of infected cells. However, the occlusion bodies produced by all constructs exhibited similar appearance ( Fig. 2B ).
Virus growth curves
To confirm that the deletion of ac92 led to a defect in BV production and to determine the virus replication kinetics of these constructs, quantitative polymerase chain reaction (qPCR) and 50% tissue culture infective dosage (TCID 50 ) were used to determine the BV titres in the tissue culture supernatants. Sf9 cells were transfected with vAc 92KO , vAc 92KO-AC92HA , vAc 92KO-MACO96HA , vAcBac and BV production at various times post-transfection were analyzed (Fig. 3A) . The qPCR analysis, which detects copies of viral genomes regardless of infectivity, showed that no increase in vAc 92KO and vAc 92KO-MACO96HA titers until between 48 and 72 hpt which was at least 24 h later than vAcBac. In addition the levels of BV at 96 hpt of vAc 92KO and vAc 92KO-MACO96HA were also approximately 4 and 3 logs lower than that obtained by vAcBac, respectively. vAc 92KO-AC92HA showed a slight reduction in BV compared to vAcBac but exhibited the same temporal production of BV and reached similar levels as vAcBac at 96 hpt.
To determine if infectious BV was produced, the virus titers at 6 and 72 hpt were analyzed with TCID 50 end-point dilution assays (EPDA, Fig. 3B ) and compared to the titres determined by qPCR. No infectious BV was detected from all constructs at 6 hpt. At 72 hpt very low titres of infectious BV were detected from vAc 92KO transfected cells (5.0 × 10 1 TCID 50 /ml). However, the titres at 72 hpt of vAc 92KO-AC92HA and vAcBac were 7.2 × 10 6 TCID 50 /ml and 2.6 × 10 7 TCID 50 /ml, respectively. The titer of vAc 92KO-MACO96HA reached 2.0× 10 4 TCID 50 /ml at 72 hpi, three logs higher than that of vAc 92KO but three logs lower than that of vAc 92KO-AC92HA suggesting the MACO96HA could replace AC92 but the functionality was not equivalent. The titration assays therefore demonstrated that ac92 is required for the efficient production of infectious BV.
DNA replication assay of ac92 deletion and repair viruses in Sf9 cells
The reduction of BV production caused by the loss of ac92 could be due to a reduction in viral DNA replication. Therefore to quantitatively analyze the effect of ac92 deletion on viral DNA replication, Sf9 cells were harvested at various times post-transfection and total DNA was extracted and analyzed by qPCR ( Fig. 4) . The temporal profiles of DNA replication were similar for all constructs but the levels obtained varied. For vAcBac and vAc 92KO-AC92HA DNA synthesis levels were equivalent and continued to increase up to 72 hpt. For vAc 92KO and vAc 92KO-MACO96HA the viral DNAs did not increase dramatically like vAcBac which would agree with the reduced levels of BV production and in turn the reduced production of secondary infections. At 96 hpt, the DNA level of vAc 92KO-MACO96HA showed half log increase compared with that of 72 hpt, and was greater than the levels of vAc 92KO , indicating the occurrence of new infection which is consistent to the higher production of infectious BV (Fig. 3B ). Together these results suggest that the deletion of ac92 does not affect the onset and level of DNA replication.
Expression and cellular localization of AC92 during infection
To further understand the function of ac92 in the viral life cycle, it is necessary to establish its temporal expression and cellular localization. A time course analysis of AC92 expression in infected Sf9 cells was performed using vAc 92KO-AC92HA . Infected cells were collected at various times post infection (pi), and the nuclear and cytoplasmic fractions were separated. Western blot analysis showed that AC92 was detected from 18 to 72 hpi at the size of about 33 kDa and was distributed in both the nucleus and the cytoplasm. From 18 to 24 hpi, during peak BV production, AC92 localized to a greater extent in the cytoplasm (Fig. 5A ). As a control to show the proper fractionation process, the same samples were probed with an IE1 antibody and a GP64 antibody. The presence of IE1 and GP64 exclusively in the nuclear and cytoplasmic fractions, respectively, confirmed the cell fractionation was successful.
The cellular localization of AC92 was also analyzed by immunofluorescence confocal microscopy. In uninfected Sf9, no fluorescence was detected demonstrating the specificity of HA antibody (Fig. 6A ). In cells infected by vAc 92KO-AC92HA , at 24 hpi AC92 was detected evenly throughout the cytoplasm, where in the nucleus it was distributed predominately at the periphery of the virogenic stroma (stained blue by DAPI) which is also know as the ring zone. By 48 hpi, the AC92 fluorescence signal showed even greater intensity at the periphery of the virogenic stroma and increased levels could also be detected within the virogenic stroma. At 48 hpi the cytoplasmic AC92 remained relatively evenly distributed. The AC92 localization pattern from immunofluorescence was consistent with the results obtained from the fractionation and Western blot analyses.
Expression and cellular localization of MACO96 in Sf9 cells
To determine if the expression and distribution of MACO96 in Sf9 cells resembles that of AC92, Sf9 cells were transfected by vAc 92KO-MACO96HA and collected at various times post transfection. Transfection instead of infection was used as the titres obtained from Cells were harvested and separated into the cytoplasmic (C) and nuclear (N) fractions. Fractions were separated by SDS-PAGE and probed with anti-HA to detect HA-tagged AC92 and MACO96. Duplicate blots were also probed with anti-IE1 and anti-GP64 monoclonal antibodies to detect IE0 and IE1, and GP64, respectively to confirm separation of nuclear and cytoplasmic fractions. Bound antibody was detected by with peroxidase-linked secondary antibody and visualized by chemiluminescence. vAc 92KO-MACO96HA were too low. The results showed that MACO96 presented similar distribution as AC92, detected from both the cytoplasmic and the nuclear fractionation with a greater abundance in the cytoplasm at 24 hpt and 48 hpt by Western blotting analysis (Fig. 5B) . However, when MACO96 localization was analyzed by confocal immunofluorescence microscopy, it was found that MACO96 had a similar even cytoplasmic distribution as that of AC92. However within the nucleus MACO96 was diffusely distributed at the periphery of the virogenic stroma ( Fig. 6B ) rather than the more concentrated localization observed for AC92 at both 24 and 48 hpi (Fig. 6A) . Differences in cellular localization may account for the inability of MACO96 to fully rescue vAc 92KO .
Western blot analysis of AC92 in purified BV and ODV
The previous reports have shown that AC92 is associated with ODV (Braunagel et al., 2003) . To investigate the localization of AC92 in virion and if it is also a structural protein of BV, BV and ODV were purified and analyzed by Western blot for the presence of AC92. The results (Fig. 7) showed that AC92 could be detected in both BV and ODV (lanes BV and ODV). The BV particles were also biochemically At the times indicated cells were fixed, probed with mouse monoclonal HA antibody to detect AC92HA or MACO96HA and bound antibody was detected by Alexa 635-conjugated goat anti-mouse IgG (red) and visualized using confocal microscopy. Cells were also stained with DAPI to directly visualize nuclear DNA (blue). Fig. 7 . Analysis of AC92HA in purified and fractionated virions. BV and ODV were purified using a sucrose gradient and the envelope and nucleocapsid fractions were isolated as previously described (see Materials and methods). Fractions were analyzed by SDS-PAGE and Western blotting and blots were probed with an anti-HA antibody to detect AC92HA. To confirm correct fractionation duplicate blots were probed with the AcV5 monoclonal antibody to detect the BV envelope protein GP64, and anti-VP39 to detect the nucleocapsid protein VP39. Bound antibody was detected by with peroxidase-linked secondary antibody and visualized by chemiluminescence. NC, nucleocapsid fraction; ENV, envelope fraction. fractionated into nucleocapsid and envelope fractions (lanes NC and ENV), and the Western blot analysis indicated that AC92 was localized in both nucleocapsid and envelope fractions. As a control to confirm the efficiency of the fractionation, the known nucleocapsid protein VP39 and the BV envelope-specific protein GP64 were also analyzed. Both VP39 and GP64 were observed in the expected fractions. These results showed that AC92 is associated with both BV and ODV virions but surprisingly localizes to both the nucleocapsids and envelope of BV.
Discussion
Ac92 has been found in all the baculovirus genomes sequenced so far and is one of 31 core genes (Herniou et al., 2003; Rohrmann, 2008) which suggests it performs a common key function in the baculovirus life cycle. Previous studies have shown that P33 binds the mammalian P53 protein and in addition more recently it has been shown to have FAD-linked sulfhydryl oxidase activity. In this study we generated an ac92 deletion virus, vAc 92KO , to determine its role in the virus life cycle. Previously proteomic analysis showed that AcMNPV AC92 is a component of ODV (Braunagel et al., 2003) . In this study, AC92 was also shown to be a structural protein of BV where it localized to both the nucleocapsid and envelope fraction (Fig. 7) . Therefore, AC92 is the fourteenth AcMNPV BV and ODV nucleocapsid protein identified, along with P78/83 , VP1054, FP25, VLF-1, VP39, BV/ODV-C42, P87, P24, 38 K, AC96, AC109, EXON0 (AC141) and AC142 (Braunagel et al., 1999; Braunagel et al., 2001; Fang et al., 2007; Fang et al., 2009; Lu and Carstens, 1992; Olszewski and Miller, 1997; Thiem and Miller, 1989; Wolgamot et al., 1993; Wu et al., 2008; Yang and Miller, 1998) . Replication analysis showed that ac92 deletion does not interfere the viral DNA replication but severely affects BV production. The FAD-linked sulfhydryl oxidase activity of AC92 was speculated to regulate the functions of the baculoviral singlestranded DNA binding proteins (SSB) LEF-3 and DBP by affecting the oxidized and reduced state of the proteins (Long et al., 2009 ). However, deletion of ac92 did not have a major impact on viral DNA replication. This result suggests that if AC92 does regulate SSB proteins it is not required for viral DNA replication and is involved in other processes. vAc 92KO was able to produce extremely low levels of infectious BV (Fig. 3) even though AC92 was shown to be a potential structural protein localized to both the nucleocapsid and envelope fractions of BV (Fig. 7) . This indicates that AC92 is not absolutely essential for the assembly of nucleocapsids or for the egress and budding of nucleocapsids, but is required for the efficient high level production of BV since the level of production was dramatically reduced (1.66 × 10 8 TCID 50 /ml to 5. 0 × 10 1 TCID 50 /ml). It is also possible that the low titre may be due to cell disintegration and release of ODV which has low infectivity in tissue culture cells (Lynn, 2003) . Sulfhydryl oxidases have been identified in many families of DNA viruses (Hakim and Fass, 2009 ) likely due to the need to generate cytosolic disulphide bridges in locations where host enzymes do not normally exist. For all baculoviruses assembly of virions occurs within the nucleus or remnants of the nucleus, a non-traditional location for enzymes involved in the formation of disulphide bridges. Similar to the results of this study the African swine fever virus protein pB119L and the vaccinia virus late protein E10R which have FAD-linked disulfhydryl oxidase activity are also required for the production of virions. Deletion of B119L decreases the number of viral particles by 90% and also results in the production of aberrant virions (Rodriguez et al., 2006) . Vaccinia virus in addition to E10R encodes two additional proteins that provide the complete pathway for disulphide bond formation (Senkevich et al., 2002) . Deletion of the E10R results in a 100 fold reduction of virus titres and electron microscopy showed aberrant virion morphogenesis. Mutation of the cysteines in the conserved E10R C-X-X-C redox active site of the sulhydryl oxidase domain also resulted in the reduction of virus titres which shows that the enzyme activity is required for the virus production. However, in this study substitution of AC92 with MACO96 which contains the conserved enzyme domain identified by Long et al. (2009) could only partially rescue vAc 92KO . This would suggest that supplying FAD-linked sulfhydryl oxidase activity is not all that is required for AC92 function, however, enzymatic activity of MACO96 still needs to be confirmed. As AC92 appears to be a structural protein (Fig. 7) it is possible that the efficiency of assembly of nucleocapsids is affected in vAc 92KO and even though MACO96 may supply the enzymatic activity it may not be able to interact correctly with other viral or host proteins. Alternatively, reduced BV from the maco96 repair may be a result of differential timing of MACO96 expression in the heterologous system. Cellular localization analysis of AC92 and MACO96 showed that both proteins localized to both the cytoplasm and the nucleus, but MACO96 had a more diffused pattern compared with that of AC92. It is possible that the enrichment of AC92 at the ring zone, not observed with MACO96, is required for the high production of BV. In a concurrent study of an ac92 knockout virus, Wu and Passarelli (2010) have shown by electron microscopy that virogenic stroma, nucleocapsids and polyhedra formed correctly but multiply enveloped ODV failed to form in the nuclear ring zone. This observation would correspond with our confocal fluorescence microscopy results showing that AC92 accumulates in the ring zone at late times post-infection.
In summary this study has shown that AC92 for which there are homologues found in all known baculoviruses plays a key role in virion morphogenesis and is essential for the successful baculovirus infection. Determining which viral or host proteins are substrates for AC92 should identify key aspects of baculovirus structure and probably also mechanisms of BV assembly and egress pathways.
Materials and methods
Viruses and cells
Spodoptera frugiperda Sf9 cells were maintained in 10% fetal bovine serum-supplemented TC100 medium at 27°C. AcMNPV recombinant bacmids were derived from the bacmid bMON14272 (Invitrogen Life Technologies) and propagated in E. coli strain DH10B.
Construction of bMON 14272 ac92null and repaired bacmid
A zeocin resistance gene was amplified using primers 1290 (5'-ACAAGTACAGCACGATCGTTTTGCTAGTCGCCATGATACCGCTGCT-TATCTTTTTATCTTTTCGGATCTCTGCAGCAC-3') and 1291 (5'-TTATTG-CAAATTTAACAATTTTTTGTATTCTCCCCATGTCATGCGTTCGTTC-GAGGTCGACCCCCCTG-3') and p2ZeoKS as the template. These primers contain 44 and 50 bp sequences homologous to the upstream and downstream flanking regions of ac92, respectively. In the ac92null bacmid, 50 nt of the 3' end of ac92 was kept to preserve the putative late motif for ac91 (TTAAG) and 12 nt of the 5' end was kept to preserve the ac93 transcriptional start site. The internal 718 nt of ac92 were replaced by the zeocin resistance gene under control of the EM7 bacterial promoter as previously described (Stewart et al., 2005) . The PCR fragment of the zeocin resistance gene was gel purified and electroporated into E. coli BW25113-pKD46 cells, which already contained the AcMNPV bacmid bMON14272 DNA. The electroporated cells were incubated at 37°C for 4 h in 3 ml of SOC medium and placed onto agar medium containing 30 μg of zeocin per ml and 50 μg of kanamycin per ml. These plates were incubated at 37°C overnight, and colonies resistant to zeocin and kanamycin were selected for further confirmation by PCR.
Two different pairs of primers were used to confirm that ac92 had been deleted from the ac92 locus of the AcMNPV bacmid genome (Fig. 1 ). Primers 1292 (5'-AAATGGCCGTGATAAACT-3') and 1014 (5'-CCGATATACTATGCCGATGAT T-3'), 1293 (5'-GTGGAGGTGTAGG-TAACG-3') and 1239 (5'-CTGACCGACGCCGACCAA-3') were used to detect the correct insertion of the zeocin gene cassette at the two junctions of ac92 locus. Fragments of 436 bp and 320 bp which were amplified with primers 1292/1014 and 1293/1239 from the ac92 deletion bacmid confirmed the correct insertion of zeocin in the ac92 locus. One of the recombinant bacmids confirmed by PCR was selected and named ac92null.
To tag AC92 with the influenza HA epitope (CYPYDVPDYASL) at the C-terminus, ac92 was amplified from bMON14272 AcBac with the primers 1647 (5'-GCGCTGCAGTGATAACGTTGCTTCCGAA-3') and 1648 (5'-GCGTCTAGATTAGGCGTAGTCGGGCACGTCGTAGGGGTATTG-CAAATTTAACAATTTTTTG-3') which places the HA tag sequence in frame with the ac92 ORF at the 3' end. The ac92 homologue from MacoNPV maco96 was amplified with primer 1649 (5'-GCGCTGCAG-TAGCGTGTTAACACCGAA-3') and 1650 (5'-GCGTCTAGATTAGGCG-TAGTCGGGCACGTCGTAGGGGTATTTTATTTCTAGTAACGATTT-3') which places the HA tag sequence at the 3' end of the ORF. The ac92HA and maco96HA PCR fragments contain their native promoters and were digested with PstI and XbaI, cloned into the same sites of pFAcT-GFP-Tnie1p(A) (Fig. 1) ). In the resulting transfer plasmids pFAcT-ac92HA and pFAcT-maco96HA, which have a Trichoplusia ni SNPV ie1 poly(A) downstream the ac92HA, maco96HA genes and polyhedrin, gfp genes as markers, were confirmed by restriction enzyme digestion and sequencing. Both ac92HA, maco96HA were introduced back into ac92null by Tn7-mediated transposition as previously described by Luckow et al. (1993) by transformation with transfer vectors pFAcT-GFP-Tnie1p(A), pFAcT-ac92HA and pFAcT-maco96HA, the resulting viruses were named vAc 92KO , vAc 92KO-AC92HA , vAc 92KO-MACO96HA .
Time course analysis of BV production and DNA replication
Sf9 cells (1.0 × 10 6 cells/35-mm-diameter well) were transfected with 1.0 μg of each bacmid (vAc 92KO , vAc 92KO-AC92HA , vAc 92KO-MACO96HA or vAcBac). At various hours post transfection, supernatant containing BV was harvested and cell debris was removed by centrifugation (8000g for 5 min). Infected cells were washed once with phosphatebuffered saline (PBS, 137 mM NaCl, 10 mM Phosphate, 2.7 mM KCl, pH7.4), scraped off with rubber policemen and pelleted by centrifugation at 800g for 5 min. Supernatant was removed and the pellets were stored at −80°C until analysis. The BV production and viral DNA replication analysis by qPCR were done as described by Nie et al. (2009) . BV titres at 6 and 72 hpt were also titrated in duplicate by end point dilution in Sf9 cells with 96-well microtiter plates or by qPCR.
Fractionation of cytoplasmic and nuclear fraction
Sf9 cells (1 × 10 6 /35-mm-diameter well) were infected with vAc 92KO-AC92HA at MOI of 2 or transfected with 1 μg of vAc 12, 18, 24, 48, 72 hpi or hpt, cells were washed with PBS and scraped off with a rubber policeman, pelleted by centrifugation at 800g for 5 min. The pellets were gently resuspended in 60 μl of NP40-lysis buffer (10 mM Tris, pH 7.9, 10 mM NaCl, 5 mM MgCl 2 , 1 mM dithiothreitol, NP-40 0.5% (V/V)) and incubated on ice for 5 min. Cytoplasmic and nuclear fractions were separated by centrifugation at 1000g for 3 min. The nuclear pellets were resuspended in the same volume of NP40-lysis buffer. Equal volume of 2× SDS protein sample buffer (PSB, 0.25 M Tris-HCl, pH6.8, 4%SDS, 20% glycerol (V/V), 10% 2-mercaptoethanol, 0.05% bromophenol blue) was mixed with the fractions for SDS-PAGE and Western blot analysis.
Purification of BV and ODV Sf9 cells (2.0 × 10 6 /ml) were infected with vAc 92KO-AC92HA with a MOI of 0.1 in two spinner flasks. Six days post infection, 80 ml of BV supernatants and infected cells were harvested for BV and ODV purification. Purified BV was further separated to BV envelope and nucleocapsids as previously described .
Western blot assay
Protein samples from Sf9 cell pellets and purified virions were subjected to Western blot as described previously . The antibodies used were: (i) mouse monoclonal anti-HA antibody (HA.11, Covance), 1:1,000; (ii) mouse monoclonal OpMNPV VP39, 1:3,000; (iii) mouse monoclonal IE1 antibody (1: 5,000); (iv) mouse monoclonal GP64 AcV5 antibody (1:5,000) (Hohmann and Faulkner, 1983; Pearson et al., 1988; Ross and Guarino, 1997) .
Immunofluorescence
Sf9 cells were infected with vAc 92KO-AC92HA with a MOI of 2 or transfected with vAc 92KO-MACO96HA (1 μg per 1×10 6 cells). At 24 and 48 hpi or 48 hpt, the supernatant was removed and the cells were washed once in PBS, followed by fixation in 3.5% paraformaldehyde in PBS for 10 min. The fixed cells were washed three times in PBS for 15 min, followed by permeabilization in 0.15% Triton X-100 in PBS for 15 min. The cells were then blocked for 60 min in blocking buffer (2% bovine serum albumin in PBS), followed by 1 h incubation with mouse monoclonal anti-HA antibody (1:200) (Covance, HA11). The cells were washed three times for 10 min each time in blocking buffer, followed by 1 h incubation with an Alexa 635-conjugated goat anti-mouse antibody (1:500) (Molecular Probes). The cells were subsequently washed three times for 10 min each time in PBS, followed by staining with 200 ng/ml 4', 6-diamidino-2-phenylindole (DAPI) (Sigma) and examined using a Leica confocal Microscope.
